Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 99,116 LAB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 99,116 | n/a |
| Jun 23, 2026 | GeneDx Holdings Corp. (WGS) | Exercise/Conversion | 3,576 | n/a |
| Jun 8, 2026 | GeneDx Holdings Corp. (WGS) | Purchase | 150,000 | $8.47M |
| May 21, 2026 | BIOLIFE SOLUTIONS INC (BLFS) | Sale | 300,000 | $6.79M |
| May 20, 2026 | GeneDx Holdings Corp. (WGS) | Purchase | 175,000 | $7.45M |
| May 12, 2026 | GeneDx Holdings Corp. (WGS) | Purchase | 500,000 | n/a |
| Mar 3, 2026 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 52,991 | $62.0K |
| Dec 5, 2025 | STANDARD BIOTOOLS INC. (LAB) | Purchase | 125,000 | $177.5K |
| Nov 26, 2025 | STANDARD BIOTOOLS INC. (LAB) | Purchase | 150,000 | $214.9K |
| Nov 21, 2025 | STANDARD BIOTOOLS INC. (LAB) | Purchase | 275,000 | $339.4K |